0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ocular Drug Excipient Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-11U12965
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ocular Drug Excipient Industry Research Report Growth Trends and Competitive Analysis 2022 2028
BUY CHAPTERS

Global Ocular Drug Excipient Market Research Report 2025

Code: QYRE-Auto-11U12965
Report
July 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Ocular Drug Excipient Market Size

The global market for Ocular Drug Excipient was valued at US$ 963 million in the year 2024 and is projected to reach a revised size of US$ 1449 million by 2031, growing at a CAGR of 6.1% during the forecast period.

Ocular Drug Excipient Market

Ocular Drug Excipient Market

Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ocular Drug Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Excipient.
The Ocular Drug Excipient market size, estimations, and forecasts are provided in terms of output/shipments (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ocular Drug Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ocular Drug Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Ocular Drug Excipient Market Report

Report Metric Details
Report Name Ocular Drug Excipient Market
Accounted market size in year US$ 963 million
Forecasted market size in 2031 US$ 1449 million
CAGR 6.1%
Base Year year
Forecasted years 2025 - 2031
by Type
  • Organic Compounds
  • Inorganic Compounds
by Application
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Contract Manufacturing Organizations (CMOs)
  • Others
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BASF, Beneo, Evonik, Excipact, Fuji Chemical Industries, InVitria, Innophos, JRS Pharma, IOI Oleochemical, Millipore Sigma, Mallinckrodt Pharmaceuticals, Pfanstiehl, PerkinElmer, Natoli, DFE Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ocular Drug Excipient manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Ocular Drug Excipient by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Ocular Drug Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

How fast is Ocular Drug Excipient Market growing?

Ans: The Ocular Drug Excipient Market witnessing a CAGR of 6.1% during the forecast period 2025-2031.

What is the Ocular Drug Excipient Market size in 2031?

Ans: The Ocular Drug Excipient Market size in 2031 will be US$ 1449 million.

Who are the main players in the Ocular Drug Excipient Market report?

Ans: The main players in the Ocular Drug Excipient Market are BASF, Beneo, Evonik, Excipact, Fuji Chemical Industries, InVitria, Innophos, JRS Pharma, IOI Oleochemical, Millipore Sigma, Mallinckrodt Pharmaceuticals, Pfanstiehl, PerkinElmer, Natoli, DFE Pharma

What are the Application segmentation covered in the Ocular Drug Excipient Market report?

Ans: The Applications covered in the Ocular Drug Excipient Market report are Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations (CMOs), Others

What are the Type segmentation covered in the Ocular Drug Excipient Market report?

Ans: The Types covered in the Ocular Drug Excipient Market report are Organic Compounds, Inorganic Compounds

1 Ocular Drug Excipient Market Overview
1.1 Product Definition
1.2 Ocular Drug Excipient by Type
1.2.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Organic Compounds
1.2.3 Inorganic Compounds
1.3 Ocular Drug Excipient by Application
1.3.1 Global Ocular Drug Excipient Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Pharmaceutical Companies
1.3.3 Biopharmaceutical Companies
1.3.4 Contract Manufacturing Organizations (CMOs)
1.3.5 Others
1.4 Global Market Growth Prospects
1.4.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Ocular Drug Excipient Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Ocular Drug Excipient Production Estimates and Forecasts (2020-2031)
1.4.4 Global Ocular Drug Excipient Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ocular Drug Excipient Production Market Share by Manufacturers (2020-2025)
2.2 Global Ocular Drug Excipient Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Ocular Drug Excipient, Industry Ranking, 2023 VS 2024
2.4 Global Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Ocular Drug Excipient Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Ocular Drug Excipient, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ocular Drug Excipient, Product Offered and Application
2.8 Global Key Manufacturers of Ocular Drug Excipient, Date of Enter into This Industry
2.9 Ocular Drug Excipient Market Competitive Situation and Trends
2.9.1 Ocular Drug Excipient Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ocular Drug Excipient Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ocular Drug Excipient Production by Region
3.1 Global Ocular Drug Excipient Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Ocular Drug Excipient Production Value by Region (2020-2031)
3.2.1 Global Ocular Drug Excipient Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Ocular Drug Excipient by Region (2026-2031)
3.3 Global Ocular Drug Excipient Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Ocular Drug Excipient Production Volume by Region (2020-2031)
3.4.1 Global Ocular Drug Excipient Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Ocular Drug Excipient by Region (2026-2031)
3.5 Global Ocular Drug Excipient Market Price Analysis by Region (2020-2025)
3.6 Global Ocular Drug Excipient Production and Value, Year-over-Year Growth
3.6.1 North America Ocular Drug Excipient Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Ocular Drug Excipient Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Ocular Drug Excipient Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Ocular Drug Excipient Production Value Estimates and Forecasts (2020-2031)
4 Ocular Drug Excipient Consumption by Region
4.1 Global Ocular Drug Excipient Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Ocular Drug Excipient Consumption by Region (2020-2031)
4.2.1 Global Ocular Drug Excipient Consumption by Region (2020-2025)
4.2.2 Global Ocular Drug Excipient Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Ocular Drug Excipient Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Ocular Drug Excipient Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ocular Drug Excipient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Ocular Drug Excipient Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Ocular Drug Excipient Production by Type (2020-2031)
5.1.1 Global Ocular Drug Excipient Production by Type (2020-2025)
5.1.2 Global Ocular Drug Excipient Production by Type (2026-2031)
5.1.3 Global Ocular Drug Excipient Production Market Share by Type (2020-2031)
5.2 Global Ocular Drug Excipient Production Value by Type (2020-2031)
5.2.1 Global Ocular Drug Excipient Production Value by Type (2020-2025)
5.2.2 Global Ocular Drug Excipient Production Value by Type (2026-2031)
5.2.3 Global Ocular Drug Excipient Production Value Market Share by Type (2020-2031)
5.3 Global Ocular Drug Excipient Price by Type (2020-2031)
6 Segment by Application
6.1 Global Ocular Drug Excipient Production by Application (2020-2031)
6.1.1 Global Ocular Drug Excipient Production by Application (2020-2025)
6.1.2 Global Ocular Drug Excipient Production by Application (2026-2031)
6.1.3 Global Ocular Drug Excipient Production Market Share by Application (2020-2031)
6.2 Global Ocular Drug Excipient Production Value by Application (2020-2031)
6.2.1 Global Ocular Drug Excipient Production Value by Application (2020-2025)
6.2.2 Global Ocular Drug Excipient Production Value by Application (2026-2031)
6.2.3 Global Ocular Drug Excipient Production Value Market Share by Application (2020-2031)
6.3 Global Ocular Drug Excipient Price by Application (2020-2031)
7 Key Companies Profiled
7.1 BASF
7.1.1 BASF Ocular Drug Excipient Company Information
7.1.2 BASF Ocular Drug Excipient Product Portfolio
7.1.3 BASF Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.1.4 BASF Main Business and Markets Served
7.1.5 BASF Recent Developments/Updates
7.2 Beneo
7.2.1 Beneo Ocular Drug Excipient Company Information
7.2.2 Beneo Ocular Drug Excipient Product Portfolio
7.2.3 Beneo Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Beneo Main Business and Markets Served
7.2.5 Beneo Recent Developments/Updates
7.3 Evonik
7.3.1 Evonik Ocular Drug Excipient Company Information
7.3.2 Evonik Ocular Drug Excipient Product Portfolio
7.3.3 Evonik Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Evonik Main Business and Markets Served
7.3.5 Evonik Recent Developments/Updates
7.4 Excipact
7.4.1 Excipact Ocular Drug Excipient Company Information
7.4.2 Excipact Ocular Drug Excipient Product Portfolio
7.4.3 Excipact Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Excipact Main Business and Markets Served
7.4.5 Excipact Recent Developments/Updates
7.5 Fuji Chemical Industries
7.5.1 Fuji Chemical Industries Ocular Drug Excipient Company Information
7.5.2 Fuji Chemical Industries Ocular Drug Excipient Product Portfolio
7.5.3 Fuji Chemical Industries Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Fuji Chemical Industries Main Business and Markets Served
7.5.5 Fuji Chemical Industries Recent Developments/Updates
7.6 InVitria
7.6.1 InVitria Ocular Drug Excipient Company Information
7.6.2 InVitria Ocular Drug Excipient Product Portfolio
7.6.3 InVitria Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.6.4 InVitria Main Business and Markets Served
7.6.5 InVitria Recent Developments/Updates
7.7 Innophos
7.7.1 Innophos Ocular Drug Excipient Company Information
7.7.2 Innophos Ocular Drug Excipient Product Portfolio
7.7.3 Innophos Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Innophos Main Business and Markets Served
7.7.5 Innophos Recent Developments/Updates
7.8 JRS Pharma
7.8.1 JRS Pharma Ocular Drug Excipient Company Information
7.8.2 JRS Pharma Ocular Drug Excipient Product Portfolio
7.8.3 JRS Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.8.4 JRS Pharma Main Business and Markets Served
7.8.5 JRS Pharma Recent Developments/Updates
7.9 IOI Oleochemical
7.9.1 IOI Oleochemical Ocular Drug Excipient Company Information
7.9.2 IOI Oleochemical Ocular Drug Excipient Product Portfolio
7.9.3 IOI Oleochemical Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.9.4 IOI Oleochemical Main Business and Markets Served
7.9.5 IOI Oleochemical Recent Developments/Updates
7.10 Millipore Sigma
7.10.1 Millipore Sigma Ocular Drug Excipient Company Information
7.10.2 Millipore Sigma Ocular Drug Excipient Product Portfolio
7.10.3 Millipore Sigma Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Millipore Sigma Main Business and Markets Served
7.10.5 Millipore Sigma Recent Developments/Updates
7.11 Mallinckrodt Pharmaceuticals
7.11.1 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Company Information
7.11.2 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product Portfolio
7.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Mallinckrodt Pharmaceuticals Main Business and Markets Served
7.11.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates
7.12 Pfanstiehl
7.12.1 Pfanstiehl Ocular Drug Excipient Company Information
7.12.2 Pfanstiehl Ocular Drug Excipient Product Portfolio
7.12.3 Pfanstiehl Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Pfanstiehl Main Business and Markets Served
7.12.5 Pfanstiehl Recent Developments/Updates
7.13 PerkinElmer
7.13.1 PerkinElmer Ocular Drug Excipient Company Information
7.13.2 PerkinElmer Ocular Drug Excipient Product Portfolio
7.13.3 PerkinElmer Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.13.4 PerkinElmer Main Business and Markets Served
7.13.5 PerkinElmer Recent Developments/Updates
7.14 Natoli
7.14.1 Natoli Ocular Drug Excipient Company Information
7.14.2 Natoli Ocular Drug Excipient Product Portfolio
7.14.3 Natoli Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.14.4 Natoli Main Business and Markets Served
7.14.5 Natoli Recent Developments/Updates
7.15 DFE Pharma
7.15.1 DFE Pharma Ocular Drug Excipient Company Information
7.15.2 DFE Pharma Ocular Drug Excipient Product Portfolio
7.15.3 DFE Pharma Ocular Drug Excipient Production, Value, Price and Gross Margin (2020-2025)
7.15.4 DFE Pharma Main Business and Markets Served
7.15.5 DFE Pharma Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ocular Drug Excipient Industry Chain Analysis
8.2 Ocular Drug Excipient Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ocular Drug Excipient Production Mode & Process Analysis
8.4 Ocular Drug Excipient Sales and Marketing
8.4.1 Ocular Drug Excipient Sales Channels
8.4.2 Ocular Drug Excipient Distributors
8.5 Ocular Drug Excipient Customer Analysis
9 Ocular Drug Excipient Market Dynamics
9.1 Ocular Drug Excipient Industry Trends
9.2 Ocular Drug Excipient Market Drivers
9.3 Ocular Drug Excipient Market Challenges
9.4 Ocular Drug Excipient Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Ocular Drug Excipient Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Ocular Drug Excipient Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Ocular Drug Excipient Production Capacity (Kiloton) by Manufacturers in 2024
 Table 4. Global Ocular Drug Excipient Production by Manufacturers (2020-2025) & (Kiloton)
 Table 5. Global Ocular Drug Excipient Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Ocular Drug Excipient Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Ocular Drug Excipient Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Ocular Drug Excipient, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Ocular Drug Excipient as of 2024)
 Table 10. Global Market Ocular Drug Excipient Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Ocular Drug Excipient, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Ocular Drug Excipient, Product Offered and Application
 Table 13. Global Key Manufacturers of Ocular Drug Excipient, Date of Enter into This Industry
 Table 14. Global Ocular Drug Excipient Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ocular Drug Excipient Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Ocular Drug Excipient Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Ocular Drug Excipient Production Value Market Share by Region (2020-2025)
 Table 19. Global Ocular Drug Excipient Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Ocular Drug Excipient Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Ocular Drug Excipient Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 22. Global Ocular Drug Excipient Production (Kiloton) by Region (2020-2025)
 Table 23. Global Ocular Drug Excipient Production Market Share by Region (2020-2025)
 Table 24. Global Ocular Drug Excipient Production (Kiloton) Forecast by Region (2026-2031)
 Table 25. Global Ocular Drug Excipient Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Ocular Drug Excipient Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Ocular Drug Excipient Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Ocular Drug Excipient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 29. Global Ocular Drug Excipient Consumption by Region (2020-2025) & (Kiloton)
 Table 30. Global Ocular Drug Excipient Consumption Market Share by Region (2020-2025)
 Table 31. Global Ocular Drug Excipient Forecasted Consumption by Region (2026-2031) & (Kiloton)
 Table 32. Global Ocular Drug Excipient Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 34. North America Ocular Drug Excipient Consumption by Country (2020-2025) & (Kiloton)
 Table 35. North America Ocular Drug Excipient Consumption by Country (2026-2031) & (Kiloton)
 Table 36. Europe Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 37. Europe Ocular Drug Excipient Consumption by Country (2020-2025) & (Kiloton)
 Table 38. Europe Ocular Drug Excipient Consumption by Country (2026-2031) & (Kiloton)
 Table 39. Asia Pacific Ocular Drug Excipient Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Table 40. Asia Pacific Ocular Drug Excipient Consumption by Region (2020-2025) & (Kiloton)
 Table 41. Asia Pacific Ocular Drug Excipient Consumption by Region (2026-2031) & (Kiloton)
 Table 42. Latin America, Middle East & Africa Ocular Drug Excipient Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Kiloton)
 Table 43. Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2020-2025) & (Kiloton)
 Table 44. Latin America, Middle East & Africa Ocular Drug Excipient Consumption by Country (2026-2031) & (Kiloton)
 Table 45. Global Ocular Drug Excipient Production (Kiloton) by Type (2020-2025)
 Table 46. Global Ocular Drug Excipient Production (Kiloton) by Type (2026-2031)
 Table 47. Global Ocular Drug Excipient Production Market Share by Type (2020-2025)
 Table 48. Global Ocular Drug Excipient Production Market Share by Type (2026-2031)
 Table 49. Global Ocular Drug Excipient Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Ocular Drug Excipient Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Ocular Drug Excipient Production Value Market Share by Type (2020-2025)
 Table 52. Global Ocular Drug Excipient Production Value Market Share by Type (2026-2031)
 Table 53. Global Ocular Drug Excipient Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Ocular Drug Excipient Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Ocular Drug Excipient Production (Kiloton) by Application (2020-2025)
 Table 56. Global Ocular Drug Excipient Production (Kiloton) by Application (2026-2031)
 Table 57. Global Ocular Drug Excipient Production Market Share by Application (2020-2025)
 Table 58. Global Ocular Drug Excipient Production Market Share by Application (2026-2031)
 Table 59. Global Ocular Drug Excipient Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Ocular Drug Excipient Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Ocular Drug Excipient Production Value Market Share by Application (2020-2025)
 Table 62. Global Ocular Drug Excipient Production Value Market Share by Application (2026-2031)
 Table 63. Global Ocular Drug Excipient Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Ocular Drug Excipient Price (US$/Ton) by Application (2026-2031)
 Table 65. BASF Ocular Drug Excipient Company Information
 Table 66. BASF Ocular Drug Excipient Specification and Application
 Table 67. BASF Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. BASF Main Business and Markets Served
 Table 69. BASF Recent Developments/Updates
 Table 70. Beneo Ocular Drug Excipient Company Information
 Table 71. Beneo Ocular Drug Excipient Specification and Application
 Table 72. Beneo Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Beneo Main Business and Markets Served
 Table 74. Beneo Recent Developments/Updates
 Table 75. Evonik Ocular Drug Excipient Company Information
 Table 76. Evonik Ocular Drug Excipient Specification and Application
 Table 77. Evonik Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Evonik Main Business and Markets Served
 Table 79. Evonik Recent Developments/Updates
 Table 80. Excipact Ocular Drug Excipient Company Information
 Table 81. Excipact Ocular Drug Excipient Specification and Application
 Table 82. Excipact Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Excipact Main Business and Markets Served
 Table 84. Excipact Recent Developments/Updates
 Table 85. Fuji Chemical Industries Ocular Drug Excipient Company Information
 Table 86. Fuji Chemical Industries Ocular Drug Excipient Specification and Application
 Table 87. Fuji Chemical Industries Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Fuji Chemical Industries Main Business and Markets Served
 Table 89. Fuji Chemical Industries Recent Developments/Updates
 Table 90. InVitria Ocular Drug Excipient Company Information
 Table 91. InVitria Ocular Drug Excipient Specification and Application
 Table 92. InVitria Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. InVitria Main Business and Markets Served
 Table 94. InVitria Recent Developments/Updates
 Table 95. Innophos Ocular Drug Excipient Company Information
 Table 96. Innophos Ocular Drug Excipient Specification and Application
 Table 97. Innophos Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Innophos Main Business and Markets Served
 Table 99. Innophos Recent Developments/Updates
 Table 100. JRS Pharma Ocular Drug Excipient Company Information
 Table 101. JRS Pharma Ocular Drug Excipient Specification and Application
 Table 102. JRS Pharma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. JRS Pharma Main Business and Markets Served
 Table 104. JRS Pharma Recent Developments/Updates
 Table 105. IOI Oleochemical Ocular Drug Excipient Company Information
 Table 106. IOI Oleochemical Ocular Drug Excipient Specification and Application
 Table 107. IOI Oleochemical Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. IOI Oleochemical Main Business and Markets Served
 Table 109. IOI Oleochemical Recent Developments/Updates
 Table 110. Millipore Sigma Ocular Drug Excipient Company Information
 Table 111. Millipore Sigma Ocular Drug Excipient Specification and Application
 Table 112. Millipore Sigma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Millipore Sigma Main Business and Markets Served
 Table 114. Millipore Sigma Recent Developments/Updates
 Table 115. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Company Information
 Table 116. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Specification and Application
 Table 117. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Mallinckrodt Pharmaceuticals Main Business and Markets Served
 Table 119. Mallinckrodt Pharmaceuticals Recent Developments/Updates
 Table 120. Pfanstiehl Ocular Drug Excipient Company Information
 Table 121. Pfanstiehl Ocular Drug Excipient Specification and Application
 Table 122. Pfanstiehl Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. Pfanstiehl Main Business and Markets Served
 Table 124. Pfanstiehl Recent Developments/Updates
 Table 125. PerkinElmer Ocular Drug Excipient Company Information
 Table 126. PerkinElmer Ocular Drug Excipient Specification and Application
 Table 127. PerkinElmer Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. PerkinElmer Main Business and Markets Served
 Table 129. PerkinElmer Recent Developments/Updates
 Table 130. Natoli Ocular Drug Excipient Company Information
 Table 131. Natoli Ocular Drug Excipient Specification and Application
 Table 132. Natoli Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 133. Natoli Main Business and Markets Served
 Table 134. Natoli Recent Developments/Updates
 Table 135. DFE Pharma Ocular Drug Excipient Company Information
 Table 136. DFE Pharma Ocular Drug Excipient Specification and Application
 Table 137. DFE Pharma Ocular Drug Excipient Production (Kiloton), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 138. DFE Pharma Main Business and Markets Served
 Table 139. DFE Pharma Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Ocular Drug Excipient Distributors List
 Table 143. Ocular Drug Excipient Customers List
 Table 144. Ocular Drug Excipient Market Trends
 Table 145. Ocular Drug Excipient Market Drivers
 Table 146. Ocular Drug Excipient Market Challenges
 Table 147. Ocular Drug Excipient Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ocular Drug Excipient
 Figure 2. Global Ocular Drug Excipient Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Ocular Drug Excipient Market Share by Type: 2024 VS 2031
 Figure 4. Organic Compounds Product Picture
 Figure 5. Inorganic Compounds Product Picture
 Figure 6. Global Ocular Drug Excipient Market Value by Application, (US$ Million) & (2020-2031)
 Figure 7. Global Ocular Drug Excipient Market Share by Application: 2024 VS 2031
 Figure 8. Pharmaceutical Companies
 Figure 9. Biopharmaceutical Companies
 Figure 10. Contract Manufacturing Organizations (CMOs)
 Figure 11. Others
 Figure 12. Global Ocular Drug Excipient Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Ocular Drug Excipient Production Value (US$ Million) & (2020-2031)
 Figure 14. Global Ocular Drug Excipient Production Capacity (Kiloton) & (2020-2031)
 Figure 15. Global Ocular Drug Excipient Production (Kiloton) & (2020-2031)
 Figure 16. Global Ocular Drug Excipient Average Price (US$/Ton) & (2020-2031)
 Figure 17. Ocular Drug Excipient Report Years Considered
 Figure 18. Ocular Drug Excipient Production Share by Manufacturers in 2024
 Figure 19. Global Ocular Drug Excipient Production Value Share by Manufacturers (2024)
 Figure 20. Ocular Drug Excipient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. The Global 5 and 10 Largest Players: Market Share by Ocular Drug Excipient Revenue in 2024
 Figure 22. Global Ocular Drug Excipient Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 23. Global Ocular Drug Excipient Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. Global Ocular Drug Excipient Production Comparison by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Figure 25. Global Ocular Drug Excipient Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. North America Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Europe Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. China Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Japan Ocular Drug Excipient Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Ocular Drug Excipient Consumption by Region: 2020 VS 2024 VS 2031 (Kiloton)
 Figure 31. Global Ocular Drug Excipient Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 33. North America Ocular Drug Excipient Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 35. Canada Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 36. Europe Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 37. Europe Ocular Drug Excipient Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 39. France Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 40. U.K. Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 41. Italy Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 42. Russia Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 43. Asia Pacific Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 44. Asia Pacific Ocular Drug Excipient Consumption Market Share by Region (2020-2031)
 Figure 45. China Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 46. Japan Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 47. South Korea Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 48. China Taiwan Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 49. Southeast Asia Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 50. India Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 51. Latin America, Middle East & Africa Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 52. Latin America, Middle East & Africa Ocular Drug Excipient Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 54. Brazil Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 55. Turkey Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 56. GCC Countries Ocular Drug Excipient Consumption and Growth Rate (2020-2031) & (Kiloton)
 Figure 57. Global Production Market Share of Ocular Drug Excipient by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Ocular Drug Excipient by Type (2020-2031)
 Figure 59. Global Ocular Drug Excipient Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Production Market Share of Ocular Drug Excipient by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Ocular Drug Excipient by Application (2020-2031)
 Figure 62. Global Ocular Drug Excipient Price (US$/Ton) by Application (2020-2031)
 Figure 63. Ocular Drug Excipient Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners